Table of Contents
ODAC Meeting
Challenges in Pediatric Cancer Drug Development
Phase 1 Design: Optimum Biologic Dose
Phase 1 Design: Starting Dose
Phase 1 Trial Design: Pharmacology
Challenges in Pediatric Cancer Drug Development
Efficacy Extrapolation
Challenges in Pediatric Cancer Drug Development
Combination Studies
Combination Studies
RMP-7/Carboplatin Phase I Trial
Genasense Phase 1 Trial
Challenges in Pediatric Cancer Drug Development
Challenges in Pediatric Cancer Drug Development
Prioritization
Pre-clinical Models
Challenges in Pediatric Cancer Drug Development
|
Author: Peter C. Adamson
|